4 completed, 1 recruiting, 1 terminated. 6 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 4, Recruiting 1, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Temporomandibular Disorders: new trials by email Literature Review of Temporomandibular Disorders trials Research Report on Temporomandibular Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Peripheral TMD Pain Mechanisms and the Effect by Botulinum Toxin A Botulinum toxin type A, Isotonic saline 0,9% - Temporomandibular Disorders | Phase 2 | Recruiting | Karolinska Institutet | 100 | 2023-11-14 | 2026-08-05 |
| Erenumab-aooe for Temporomandibular Disorders Management: TMD Cgrp Antibody RElief (TMD CARE) Erenumab-Aooe 70 MG in 1 mL Prefilled Syringe, Placebo - Temporomandibular Disorders | Phase 2 | Terminated | University of Maryland, Baltimore | 5 | 2022-05-26 | 2024-04-02 |
| Study of Orofacial Pain and PropRANOlol Propranolol ER, Placebo - Temporomandibular Disorders | Phase 2 | Completed | University of North Carolina, Chapel Hill | 200 | 2015-08-20 | 2019-05-21 |
| Biofeedback-Based Cognitive Behavioral Treatment for Temporomandibular Disorders Biofeedback-Based Cognitive Behavioral Treatment, Dental treatment with occlusal splint (OS) - Temporomandibular Disorders | Phase 2 / Phase 3 | Completed | Philipps University Marburg | 58 | 2008-08-01 | 2013-12-30 |
| Treatment Outcomes for Temporomandibular Disorders (TMD) Via the Clayton Intra-aural Device (CID) Clinical Trial Clayton Intra-aural Device (CID), Mouth Splint, Exercise Group - Temporomandibular Disorders | Phase 1 / Phase 2 | Completed | Ascentia Health, Inc. | 152 | 2008-04-01 | 2010-08-24 |
| Nasal Carbon Dioxide (CO2)for the Treatment of Temporomandibular Disorders (TMD)Related Pain Nasal Carbon Dioxide, Air - Temporomandibular Disorders, Pain | Phase 2 | Completed | Capnia, Inc. | 100 | 2007-02-01 | 2010-08-20 |
Temporomandibular Joint Disorders (6) · Pain (3) · Agnosia (1) · Craniomandibular Disorders (1) · Headache (1) · Musculoskeletal Diseases (1) · Myalgia (1) · Myofascial Pain Syndromes (1) · Stomatognathic Diseases (1) · Temporomandibular Joint Dysfunction Syndrome (1)
Jaw Diseases (6) · Joint Diseases (6) · Mandibular Diseases (6) · Muscular Diseases (6) · Craniomandibular Disorders (5) · Musculoskeletal Diseases (5) · Stomatognathic Diseases (5) · Neurologic Manifestations (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Nervous System Diseases (2) · Musculoskeletal Pain (1) · Neurobehavioral Manifestations (1) · Neuromuscular Diseases (1) · Perceptual Disorders (1)
Air (1) · Botulinum Toxins, Type A (1) · Dental Care (1) · Occlusal Splints (1) · Propranolol (1) · Sugars (1) · erenumab (1)
Ascentia Health, Inc. (1) · Capnia, Inc. (1) · Karolinska Institutet (1) · Philipps University Marburg (1) · University of Maryland, Baltimore (1) · University of North Carolina, Chapel Hill (1)
United States (3) · Germany (1) · Mexico (1) · Sweden (1)
Alejandro Tsuchiya, DDS (1) · Edward L. Truelove, DDS, MSD (1) · Gaby M Bleichhardt, Dr. (PhD) (1) · Inna E. Tchivileva, MD (1) · Lawrence G. Clayton, M.A. (1) · Malin Ernberg (1) · Meike C Shedden Mora, Dipl. Psych. (1) · Richard Ohrbach, DDS, PhD (1) · Roger B. Fillingim, PhD (1) · Winfried Rief, Prof. Dr. (1)
PMID 22916669, PMID 22980538, PMID 23446073, PMID 32297945, PMID 32701836, PMID 33030089, PMID 33560875, PMID 34022805
U01DE024169 (1)